ATHIRA PHARMA INC's ticker is ATHA and the CUSIP is 04746L104. A total of 95 filers reported holding ATHIRA PHARMA INC in Q3 2021. The put-call ratio across all filers is 1.95 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $539,433 | -48.7% | 267,046 | -25.1% | 0.00% | -66.7% |
| Q2 2023 | $1,052,238 | -0.1% | 356,691 | -15.4% | 0.00% | 0.0% |
| Q1 2023 | $1,053,513 | -2.4% | 421,405 | +23.8% | 0.00% | 0.0% |
| Q4 2022 | $1,078,868 | +0.7% | 340,337 | -5.6% | 0.00% | -25.0% |
| Q3 2022 | $1,071,000 | +26.1% | 360,643 | +29.5% | 0.00% | +33.3% |
| Q2 2022 | $849,000 | -7.8% | 278,433 | +307.9% | 0.00% | 0.0% |
| Q1 2022 | $921,000 | -56.3% | 68,257 | -57.8% | 0.00% | -40.0% |
| Q4 2021 | $2,109,000 | +0.7% | 161,880 | -27.5% | 0.01% | 0.0% |
| Q3 2021 | $2,094,000 | +159.5% | 223,201 | +183.2% | 0.01% | +150.0% |
| Q2 2021 | $807,000 | – | 78,800 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| VR Adviser, LLC | 1,691,623 | $57,938,000 | 8.52% |
| ACUTA CAPITAL PARTNERS, LLC | 393,000 | $13,460,000 | 3.66% |
| Logos Global Management LP | 947,873 | $32,465,000 | 2.78% |
| RTW INVESTMENTS, LP | 2,685,779 | $88,899,000 | 1.49% |
| Avidity Partners Management LP | 1,043,873 | $35,753,000 | 1.16% |
| Perceptive Advisors | 3,114,805 | $106,682,000 | 1.14% |
| Sofinnova Investments, Inc. | 509,168 | $17,439,000 | 1.04% |
| HighVista Strategies LLC | 32,062 | $1,098,000 | 0.70% |
| Rock Springs Capital Management LP | 860,902 | $29,486,000 | 0.62% |
| PFM Health Sciences, LP | 470,227 | $16,105,000 | 0.57% |